Health chief warns hospitals over Dengvaxia case refusal

admin   •   March 15, 2018   •   4063

Department of Health Secretary Francisco Duque III

MANILA, Philippines — Hospitals will face cancellation of PhilHealth accreditations and licenses if proven to have rejected emergency cases especially those Dengvaxia-related concerns.

This is a warning made by Health Secretary Francisco Duque III during his inspection at San Lorenzo Ruiz Women’s Hospital in Malabon and in Navotas City hospitals on Thursday.

He stressed that government hospitals are obliged to setup dengue or Dengvaxia fast lane to prioritize patients with such cases.

“Kung ang inyo pong mga tanggapan ay punung-puno ng pasyente (If your office is filled with patients), it still does not exempt you from giving emergency care,” said the health chief.

Duque said that experts from UP-PGH are continuing with their investigation on Dengvaxia-linked deaths.

Out of 14 bodies of children they examined, three were linked to the Dengvaxia vaccination.

“They died of dengue shock syndrome. And their theory is, it could be because of vaccine failure or the phenomenon of antibody-dependent enhancement,” said Duque.

Meanwhile, the secretary is leaving it up to the Senate whatever the outcome of the investigation on Dengvaxia will be and vows to respect its result.

“Senator Gordon is a topnotch lawyer. So I would want to respect whatever is the outcome of the investigation that was conducted,” said the health secretary. — Rey Pelayo | UNTV News & Rescue

Leptospirosis case now over 900; NKTI gym, converted into leptos ward

Maris Federez   •   August 20, 2019

The National Kidney and Transplant Institute (NKTI) has turned its gymnasium into an alternative ward for leptospirosis patients.

This is to accommodate patients with leptospirosis and be provided with immediate treatment for the deadly disease.

The Department of Health (DOH) said the recent rains that caused flooding had contributed to the increase in the number of leptospirosis patients in Metro Manila alone.

To date, the DOH has recorded 106 fatalities and more than 900 cases of leptospirosis. 300 of which are from the NCR.

“It’s really a problem because you know the environmental, sanitation and hygiene do affect the health of our people because the local government, for example, do not do their efficient garbage collection, so certainly it raises the risk of the populace,” DOH Sec. Francisco Duque added.

This, however, is still low compared to what was recorded last year in the last 2 years.

The DOH then urged the public to maintain cleanliness in their respective surroundings to prevent leptospirosis. (with details from Mai Bermudez) /mbmf

Number of dengue cases in NCR exceeds alert threshold – DOH

Maris Federez   •   August 16, 2019

A child suffering from dengue fever receives medical treatment at an isolation ward of a government-run hospital in Manila, Philippines, 16 July 2019. (Photoville International)

The National Capital Region (NCR) has recorded more than 11,000 dengue cases from January to August 10 this year.

This is 33% higher than what was recorded in the past five years.

“It’s starting to rise and just like the other regions that began with the alert levels, naging epidemic level na sila [they’ve reached the epidemic level]. Pwede pa ring sumipa ang dengue. Kaya hindi ho tayo pwedeng magpahinay-hinay [Dengue case can still go up. That’s why we should not be complacent],” Department of Health (DOH) Secretary Francisco Duque said.

The cities in the NCR where dengue cases have spiked include Paranaque, Malabon, Taguig, Makati, and Mandaluyong.

The DOH clarified that no medicine, supplement, or vaccine had been proven to cure dengue.

The health department also supports the move of the Department of Science and Technology (DOST) to fund the distribution of food supplements which may help increase an individual’s platelet count to avoid dengue.

“Wala namang gamot ang dengue. Wala ring bakuna. At kung meron man sila ng inaalay na makakagamot, hindi po totoo iyan. Ito po ay food suppmement lamang at kinakailangan merong FDA certificate of product registration [There is no medicine for dengue. No vaccine either. And if there are some who offer something that’s supposed to cure dengue, it’s not true. It’s just a food supplement and it needs to have FDA certificate of product registration],” Duque added.

The health official then reminded the public to clean their surroundings and eradicate dengue-mosquito breeding areas through the 4 o’clock habit using the 4S strategy:

  • Search and Destroy
  • Self- Protection
  • Seek Early Consultation
  • Support Space Spraying

This is to further prevent the number of dengue cases in Metro Manila to further exceed the health department’s alert threshold. (from the report of Aiko Miguel) /mbmf

Sanofi Pasteur optimistic Dengvaxia will be restored in PH market

Aileen Cerrudo   •   August 15, 2019

French Pharmaceutical firm, Sanofi Pasteur expressed optimism that the Dengvaxia vaccine will be restored in the Philippine market.

In a statement, Sanofi Pasteur Philippines General Manager Jean Antoine Zinsou said they are open for a discussion with the Food and Drug Administration (FDA) and the Department of Health (DOH).

He also clarified that Dengvaxia is safe and effective to use.

According to Zinsou, the said vaccine was only banned in the Philippines because of incomplete documents or due to “administrative consideration.”

“We definitely need to settle this issue. One way to do it is to discuss with FDA and see what is needed to have this revocation lifted,” he said.

Zinsou also said Dengvaxia is registered in 20 countries across the globe and is acknowledged by the United States Food Drug Administration and the World Health Organization (WHO).

Meanwhile, Sanofi agrees with the DOH that Dengvaxia is not a solution to the Dengue epidemic in the country.

READ: Dengvaxia won’t bring dengue cases down – DOH

“The vaccines that we are mentioning is not a solution or a silver bullet for the ongoing outbreak. We are open to any discussion with the health authorities to see what is needed, what do they need for the future,” Zinsou said.

In February this year, the FDA revoked the certificate of product registration of Dengvaxia.

Sanofi already filed an appeal two weeks ago and the DOH will release their decision on the issue on August 19.—AAC (with reports from Aiko Miguel)

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+63) 396-8688 (Tel)

(+63) 2 920.8336 (Fax)

info@untvweb.com (General inquiries)

support@untvweb.com

UNTV News and Rescue Emergency Hotlines:

LANDLINE (+63) 396-8688

ADVERTISE WITH US

(+63) 2 442.6244 Loc. 143, 144, 162, 164

advertising@untvweb.com

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.